Hangzhou AGS Medtech Co Ltd Ordinary Shares - Class A 688581
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥55.90
- Day Range
- ¥57.17–64.80
- 52-Week Range
- ¥42.92–91.76
- Bid/Ask
- ¥63.71 / ¥63.90
- Market Cap
- ¥5.15 Bil
- Volume/Avg
- 2.7 Mil / 621,734
Key Statistics
- Price/Earnings (Normalized)
- 19.82
- Price/Sales
- 9.09
- Dividend Yield (Trailing)
- 2.28%
- Dividend Yield (Forward)
- 2.28%
- Total Yield
- 2.28%
Company Profile
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 592
- Website
- http://www.bioags.com
Comparables
Valuation
|
Metric
|
688581
|
603301
|
688016
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.82 | 24.38 | 22.39 |
Price/Book Value | 2.32 | 1.18 | 3.46 |
Price/Sales | 9.09 | 1.68 | 9.68 |
Price/Cash Flow | 18.61 | 10.16 | 19.38 |
Price/Earnings
688581
603301
688016
Financial Strength
|
Metric
|
688581
|
603301
|
688016
|
|---|---|---|---|
Quick Ratio | 22.00 | 1.57 | 8.91 |
Current Ratio | 22.61 | 2.24 | 9.53 |
Interest Coverage | 14,174.28 | 5.28 | 413.50 |
Quick Ratio
688581
603301
688016
Profitability
|
Metric
|
688581
|
603301
|
688016
|
|---|---|---|---|
Return on Assets (Normalized) | 11.77% | 1.65% | 16.12% |
Return on Equity (Normalized) | 12.40% | 2.34% | 18.19% |
Return on Invested Capital (Normalized) | 10.48% | 1.91% | 17.54% |
Return on Assets
688581
603301
688016
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Kjyzblrsj | Cpwvrv | $195.6 Bil | |||
| Stryker Corp
SYK
| Zbxpfspwf | Dygz | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Wntttcxs | Zvpqwwl | $122.7 Bil | |||
| Medtronic PLC
MDT
| Kjgjpmp | Lclrf | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Rtmlhkdbk | Mwntb | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Zkyp | Syzs | $30.7 Bil | |||
| DexCom Inc
DXCM
| Sntrbkxt | Bry | $27.0 Bil | |||
| Steris PLC
STE
| Jhqnyzhw | Vsrwtpr | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Rcfpkqxby | Kvl | $22.0 Bil | |||
| Insulet Corp
PODD
| Nmjdbhjlj | Swkvzc | $16.3 Bil |
United States